StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie AndroGel [legacy through FY20Q1] by Quarter

AndroGel (testosterone gel) [legacy through FY20Q1] — Worldwide net revenues ($M) ($M)

AbbVie AndroGel [legacy through FY20Q1]: $8M in Q1 2020, down 89.2% from a year earlier. That is the lowest of the 13 quarters on record here. No newer figure appears in the documents we track.

Latest, Q1 2020
8
Period ended Mar 31, 2020
Change on a year earlier
-89.2%
74 in Q1 2019
History
13 quarters
Since Q1 2017
Sources
8
Documents cited below

Where the Q1 2020 figure comes from

Source: Form 10-Q (filed 2020-05-08) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAndroGel (testosterone gel) [legacy through FY20Q1] — Worldwide net revenues ($M) ($M)Year on yearSource
Q1 2020Mar 31, 20208-89.2%Form 10-Q (filed 2020-05-08) ↗
Q4 2019Dec 31, 201923-69.7%Form 10-K (filed 2020-02-21) ↗
Q3 2019Sep 30, 201953-60.7%Form 10-Q (filed 2019-11-06) ↗
Q2 2019Jun 30, 201922-82.8%Form 10-Q (filed 2019-08-05) ↗
Q1 2019Mar 31, 201974-43.1%Form 10-Q (filed 2020-05-08) ↗
Q4 2018Dec 31, 201876-45.7%Form 10-K (filed 2020-02-21) ↗
Q3 2018Sep 30, 2018135-8.2%Form 10-Q (filed 2019-11-06) ↗
Q2 2018Jun 30, 2018128-16.9%Form 10-Q (filed 2019-08-05) ↗
Q1 2018Mar 31, 2018130-4.4%Form 10-Q (filed 2019-05-03) ↗
Q4 2017Dec 31, 2017140–Form 10-K (filed 2020-02-21) ↗
Q3 2017Sep 30, 2017147–Form 10-Q (filed 2018-11-07) ↗
Q2 2017Jun 30, 2017154–Form 10-Q (filed 2018-08-07) ↗
Q1 2017Mar 31, 2017136–Form 10-Q (filed 2018-05-04) ↗

Breakdown

What makes up androGel [legacy through FY20Q1]

Cite this data

StockData. (2026). AbbVie AndroGel [legacy through FY20Q1] ($M), quarterly Q1 2017–Q1 2020 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/androgel-ww

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.